JP2019509483A5 - - Google Patents

Info

Publication number
JP2019509483A5
JP2019509483A5 JP2018544901A JP2018544901A JP2019509483A5 JP 2019509483 A5 JP2019509483 A5 JP 2019509483A5 JP 2018544901 A JP2018544901 A JP 2018544901A JP 2018544901 A JP2018544901 A JP 2018544901A JP 2019509483 A5 JP2019509483 A5 JP 2019509483A5
Authority
JP
Japan
Application number
JP2018544901A
Other languages
Japanese (ja)
Other versions
JPWO2017144900A5 (https=
JP7246927B2 (ja
JP2019509483A (ja
Filing date
Publication date
Priority claimed from GBGB1603291.4A external-priority patent/GB201603291D0/en
Application filed filed Critical
Publication of JP2019509483A publication Critical patent/JP2019509483A/ja
Priority to JP2022017497A priority Critical patent/JP7541045B2/ja
Priority to JP2022198753A priority patent/JP7541070B2/ja
Publication of JP2019509483A5 publication Critical patent/JP2019509483A5/ja
Publication of JPWO2017144900A5 publication Critical patent/JPWO2017144900A5/ja
Application granted granted Critical
Publication of JP7246927B2 publication Critical patent/JP7246927B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018544901A 2016-02-25 2017-02-24 質量分析キット Active JP7246927B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022017497A JP7541045B2 (ja) 2016-02-25 2022-02-07 質量分析キット
JP2022198753A JP7541070B2 (ja) 2016-02-25 2022-12-13 質量分析キット

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB1603291.4A GB201603291D0 (en) 2016-02-25 2016-02-25 Antibodies
GB1603291.4 2016-02-25
US201662368606P 2016-07-29 2016-07-29
US62/368,606 2016-07-29
PCT/GB2017/050489 WO2017144900A1 (en) 2016-02-25 2017-02-24 Mass spectrometry kit

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2022017497A Division JP7541045B2 (ja) 2016-02-25 2022-02-07 質量分析キット
JP2022198753A Division JP7541070B2 (ja) 2016-02-25 2022-12-13 質量分析キット

Publications (4)

Publication Number Publication Date
JP2019509483A JP2019509483A (ja) 2019-04-04
JP2019509483A5 true JP2019509483A5 (https=) 2022-12-26
JPWO2017144900A5 JPWO2017144900A5 (https=) 2022-12-26
JP7246927B2 JP7246927B2 (ja) 2023-03-28

Family

ID=55806928

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018544901A Active JP7246927B2 (ja) 2016-02-25 2017-02-24 質量分析キット
JP2022017497A Active JP7541045B2 (ja) 2016-02-25 2022-02-07 質量分析キット
JP2022198753A Active JP7541070B2 (ja) 2016-02-25 2022-12-13 質量分析キット

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022017497A Active JP7541045B2 (ja) 2016-02-25 2022-02-07 質量分析キット
JP2022198753A Active JP7541070B2 (ja) 2016-02-25 2022-12-13 質量分析キット

Country Status (10)

Country Link
US (1) US12461108B2 (https=)
EP (2) EP4123308A1 (https=)
JP (3) JP7246927B2 (https=)
KR (1) KR102851057B1 (https=)
CN (2) CN116148479A (https=)
AU (1) AU2017222399B2 (https=)
DK (1) DK3420361T3 (https=)
ES (1) ES2936783T3 (https=)
GB (1) GB201603291D0 (https=)
WO (1) WO2017144900A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201708262D0 (en) 2017-05-23 2017-07-05 Binding Site Group Ltd Assay for plasma cell associated disease
CA3126712A1 (en) * 2019-01-31 2020-08-06 Regeneron Pharmaceuticals, Inc. Native microfluidic ce-ms analysis of antibody charge heterogeneity
CN110009008B (zh) * 2019-03-18 2020-11-06 四川大学 基于提取的免疫固定电泳图特征对其进行自动分类的方法
GB201906599D0 (en) 2019-05-10 2019-06-26 Binding Site Group Ltd Mass spectrometry calibrator
WO2020229794A1 (en) 2019-05-10 2020-11-19 The Binding Site Group Limited Mass spectrometry calibrator
GB201915946D0 (en) 2019-11-01 2019-12-18 Binding Site Group Ltd Quantitation of immunoglobulins i n mass spectrometry
GB202007047D0 (en) * 2020-05-13 2020-06-24 Binding Site Group Ltd Mass spectrometry controls
GB202008887D0 (en) * 2020-06-11 2020-07-29 Binding Site Group Ltd A method of identifying or characterising an immune response in a subject
GB202016822D0 (en) 2020-10-23 2020-12-09 Binding Site Group Ltd Quantitation of immunoglobulins in mass spectrometry
CN113720900A (zh) * 2021-09-14 2021-11-30 首都医科大学附属北京朝阳医院 一种基于madli-tof ms技术检测血清中m蛋白的方法
CN114324557B (zh) * 2021-12-03 2024-05-10 融智生物科技(青岛)有限公司 一种基于MALDI-TOF MS的ζ-珠蛋白的检测方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6290090A (en) 1989-08-29 1991-04-08 University Of Southampton Bi-or trispecific (fab)3 or (fab)4 conjugates
WO1991006570A1 (en) * 1989-10-25 1991-05-16 The University Of Melbourne HYBRID Fc RECEPTOR MOLECULES
EP1400536A1 (en) * 1991-06-14 2004-03-24 Genentech Inc. Method for making humanized antibodies
ES2242189T3 (es) * 1994-05-13 2005-11-01 Miltenyi Biotec Gmbh Columna esteril y apirogena copulada a una proteina con miras a la fijacion y extraccion de sustancias dadas de la sangre.
JP2826965B2 (ja) * 1995-01-12 1998-11-18 オリエンタル酵母工業株式会社 免疫吸着体とその製造法
EP0862584B1 (en) 1995-11-03 2004-12-22 The Binding Site Limited Production of antibodies
US6207370B1 (en) * 1997-09-02 2001-03-27 Sequenom, Inc. Diagnostics based on mass spectrometric detection of translated target polypeptides
US6897044B1 (en) 1999-01-28 2005-05-24 Biogen Idec, Inc. Production of tetravalent antibodies
WO2005035721A2 (en) * 2003-10-08 2005-04-21 Ebioscience Native immunoglobulin binding reagents and methods for making and using same
GB0501741D0 (en) * 2005-01-27 2005-03-02 Binding Site The Ltd Antibody
CA2600844A1 (en) * 2005-03-14 2006-09-21 Medimmune, Inc. Macromolecules comprising a thioether cross-link
US7781178B2 (en) 2005-04-12 2010-08-24 Akira Matsumori Biomarker for diagnosing heart disease and the use thereof
US7893616B2 (en) * 2006-02-27 2011-02-22 Ohio State University Process to determine enzyme activity
US20100015652A1 (en) 2006-12-21 2010-01-21 Brian Walter Granda Antibody quantitation
RU2012118620A (ru) 2009-10-09 2013-11-20 Симфоген А/С Множественное количественное определение в смеси индивидуальных рекомбинантных белков посредством сигнатурных пептидов и масс-спектрометрии
GB201001946D0 (en) 2010-02-05 2010-03-24 Binding Site Group The Ltd Cancer prognostic assay
GB2478520A (en) 2010-03-02 2011-09-14 Binding Site Group Ltd Kidney prognostic assay
GB201117172D0 (en) 2011-10-05 2011-11-16 Binding Site Group The Ltd Diabetes
GB201121265D0 (en) 2011-12-12 2012-01-18 Binding Site Group The Ltd Assay
JP2015510877A (ja) * 2012-03-09 2015-04-13 ユーシーエル ビジネス パブリック リミテッド カンパニー 抗体の化学修飾
WO2014121031A1 (en) 2013-01-31 2014-08-07 Excelimmune, Inc. Characterization of antibody mixtures by mass spectrometry
WO2015131169A2 (en) * 2014-02-28 2015-09-03 H. Lee Moffitt Cancer Center And Research Institute, Inc. Personalized myeloma detection
WO2015154052A1 (en) 2014-04-04 2015-10-08 Mayo Foundation For Medical Education And Research Isotyping immunoglobulins using accurate molecular mass
EP3175242A4 (en) * 2014-07-29 2017-12-27 Mayo Foundation for Medical Education and Research Quantifying monoclonal antibody therapeutics by lc-ms/ms
PT3209767T (pt) * 2014-10-21 2020-11-09 Gennova Biopharmaceuticals Ltd Um novo processo de purificação para isolamento e produção comercial de tnk-tpa recombinante (tenecteplase)
CN108026164A (zh) 2015-09-24 2018-05-11 梅约医学教育与研究基金会 通过质谱鉴定免疫球蛋白游离轻链
GB201708262D0 (en) * 2017-05-23 2017-07-05 Binding Site Group Ltd Assay for plasma cell associated disease

Similar Documents

Publication Publication Date Title
BR122021024397A2 (https=)
JP2019509483A5 (https=)
BR122021000189A2 (https=)
BR112019008823A2 (https=)
BR112020006084A8 (https=)
BR122022025811B8 (https=)
BR202018014992U2 (https=)
BR122021023687A2 (https=)
BR122021014832A2 (https=)
BR122022003518A2 (https=)
BR112020008820A2 (https=)
BR202017025154U2 (https=)
BR102017023327A2 (https=)
BR202017021228U2 (https=)
BR202017020981U2 (https=)
BR202017017068U2 (https=)
BR202017016984U2 (https=)
BR202017016924U2 (https=)
BR102017015495A2 (https=)
BR102017015250A2 (https=)
BR102017014430A2 (https=)
BR202017012548U2 (https=)
BR202017011220U2 (https=)
BR202017010814U2 (https=)
BR202017010373U2 (https=)